Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
| Status: | Enrolling by invitation |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 1/25/2019 |
| Start Date: | October 17, 2017 |
| End Date: | October 17, 2020 |
Medical Provider Experience Assessment Healthcare Decisions Post-Testing, Risk Reducing, and Preventative Strategies Using BRCA2 and BRCA2 Genetic Testing
Observational study is to increase surveillance for breast and ovarian cancers, also to
determine targeted risk-reducing and preventative strategies.
determine targeted risk-reducing and preventative strategies.
The general design of this study is collecting data and reviewing the Principal
Investigators' (P.I.) Standard Operating Procedures (SOP) on BRCA testing and changes made to
their specific SOP.
Investigators' (P.I.) Standard Operating Procedures (SOP) on BRCA testing and changes made to
their specific SOP.
Inclusion Criteria:
- Must be a Medical Practitioner
- Medical Doctor (MD)
- Doctor of Osteopathic (DO)
- Physician Assistant (PA)
- Advanced Practice Registered Nurse (APRN)
- Nurse Practitioner (NP)
- Must have a current standard operating procedure that includes obtaining/reviewing
medical history and family medical history
Exclusion Criteria:
- Government-funded insurance data cannot be included in the study.
We found this trial at
1
site
Click here to add this to my saved trials
